| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |